0.83
price up icon0.01%   0.000100
after-market アフターアワーズ: .83
loading
前日終値:
$0.8299
開ける:
$0.821
24時間の取引高:
178.09K
Relative Volume:
0.07
時価総額:
$8.93M
収益:
$1.52M
当期純損益:
$-13.97M
株価収益率:
-0.2721
EPS:
-3.05
ネットキャッシュフロー:
$-13.29M
1週間 パフォーマンス:
-2.99%
1か月 パフォーマンス:
-5.69%
6か月 パフォーマンス:
+1.22%
1年 パフォーマンス:
-20.19%
1日の値動き範囲:
Value
$0.8156
$0.8494
1週間の範囲:
Value
$0.81
$0.91
52週間の値動き範囲:
Value
$0.55
$3.06

Predictive Oncology Inc Stock (POAI) Company Profile

Name
名前
Predictive Oncology Inc
Name
セクター
Healthcare (1173)
Name
電話
412-432-1500
Name
住所
91 43RD STREET, PITTSBURGH, MN
Name
職員
24
Name
Twitter
Name
次回の収益日
2024-11-12
Name
最新のSEC提出書
Name
POAI's Discussions on Twitter

POAI を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Instruments & Supplies icon
POAI
Predictive Oncology Inc
0.83 8.93M 1.52M -13.97M -13.29M -3.05
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
543.41 189.82B 8.71B 2.48B 1.75B 6.82
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
172.25 49.98B 20.87B 1.50B 2.59B 5.24
Medical Instruments & Supplies icon
ALC
Alcon Inc
88.28 44.00B 9.93B 1.12B 1.58B 2.25
Medical Instruments & Supplies icon
RMD
Resmed Inc
258.00 37.05B 5.02B 1.31B 1.56B 8.91
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
218.80 16.36B 2.90B 467.20M 306.90M 6.37

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-08-19 開始されました H.C. Wainwright Buy

Predictive Oncology Inc (POAI) 最新ニュース

pulisher
Jun 18, 2025

Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Up 50.6% in May - Defense World

Jun 18, 2025
pulisher
Jun 12, 2025

Labcorp (LH) Gains Exclusive 3D Liver Models from Predictive Onc - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor By Investing.com - Investing.com South Africa

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops 3D Liver Toxicity Models for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Functional 3D Organoid Models Exclusively for Labcorp - MarketScreener

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology develops liver toxicity models for Labcor - Investing.com Australia

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Develops Functional 3D Organoid Models Exclusively for Labcorp - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Predictive Oncology Inc. Develops Exclusive 3D Organoid Models for Labcorp to Enhance Drug Discovery and Safety Evaluation - Nasdaq

Jun 12, 2025
pulisher
Jun 12, 2025

Revolutionary 3D Organoid Models: How Predictive Oncology's Exclusive Labcorp Deal Transforms Drug Testing - Stock Titan

Jun 12, 2025
pulisher
Jun 11, 2025

Predictive Oncology Faces Nasdaq Delisting Notice - TipRanks

Jun 11, 2025
pulisher
Jun 07, 2025

Predictive Oncology (NASDAQ:POAI) Stock Price Crosses Below 200 Day Moving Average – What’s Next? - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Major AI Breakthrough in Cancer Research: Leading Pharma Companies Unite in Revolutionary Oncology Initiative - Stock Titan

Jun 05, 2025
pulisher
Jun 02, 2025

SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow

Jun 02, 2025
pulisher
Jun 01, 2025

'It's not something you choose to do, it's something you have to do': CEO & artist shares story - WTAE

Jun 01, 2025
pulisher
May 30, 2025

Predictive Oncology (NASDAQ:POAI) Stock Crosses Below 200 Day Moving Average – Time to Sell? - Defense World

May 30, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July - GlobeNewswire

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology says court denies Renovaro motion for expedited trial - TipRanks

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology (POAI) Addresses Legal Dispute with Renovaro - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Predictive Oncology to defend against Renovaro’s claims in court - Investing.com Australia

May 27, 2025
pulisher
May 27, 2025

Court Denies Renovaro Motion for an Expedited Trial in July | POAI Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Delaware Court Rejects Renovaro's Rush to Trial Against Predictive Oncology, Cites Critical Delays - Stock Titan

May 27, 2025
pulisher
May 23, 2025

Renovaro Inc. Accelerates 2025 Lawsuit to Force Predictive Oncology Merger - MSN

May 23, 2025
pulisher
May 22, 2025

Predictive Oncology Stock Hits 1-Month Low Amid Renovaro Legal Clash, But Retail Leans Bullish By Stocktwits - Investing.com India

May 22, 2025
pulisher
May 22, 2025

UPDATERenovaro Inc. Announces Expedited Trial for 2025 Lawsui - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology (POAI) Advances AI-Driven Cancer Drug Discov - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement D - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Gets Expedited Trial in Predictive Oncology Merger Dispute - marketscreener.com

May 22, 2025
pulisher
May 22, 2025

Renovaro Sues Predictive Oncology (POAI) Over Merger Agreement Dispute | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology - The Manila Times

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology | RENB Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Secures Ruling to Expedite Trial Against Predictive Oncology Over Breach of Merger Agreement - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Court Fast-Tracks Renovaro's Lawsuit to Force Predictive Oncology Merger After 50% Stock Jump Drama - Stock Titan

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition | POAI Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery - Investing.com

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology moves to leverage biobank using AI - TipRanks

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology harnesses AI for drug discovery By Investing.com - Investing.com Nigeria

May 22, 2025
pulisher
May 22, 2025

Predictive Oncology Inc. Advances AI-Driven Drug Discovery with Extensive Biobank of Tumor Samples - Nasdaq

May 22, 2025
pulisher
May 22, 2025

AI Meets Genomics: Predictive Oncology Breakthrough Coincides with Regeneron's $256M 23andMe Acquisition - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Major AI Breakthrough: How 150,000 Live Tumor Samples Are Revolutionizing Cancer Drug Discovery - Stock Titan

May 22, 2025
pulisher
May 20, 2025

Predictive Oncology issued shareholder letter - TipRanks

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology (POAI) Showcases Recent Achievements and Future Plans | POAI Stock News - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, - GuruFocus

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Expands AI-Driven Platform to Include Biomarker Discovery and Drug Repurposing for Precision Oncology - Nasdaq

May 20, 2025
pulisher
May 20, 2025

Predictive Oncology Inc. Issues Shareholder Letter Titled, "Revolutionizing Medicine: ... - Bluefield Daily Telegraph

May 20, 2025

Predictive Oncology Inc (POAI) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$75.84
price up icon 0.50%
$189.33
price up icon 0.43%
medical_instruments_supplies COO
$71.16
price up icon 0.03%
$65.16
price up icon 0.23%
medical_instruments_supplies BAX
$30.28
price down icon 0.36%
medical_instruments_supplies WST
$218.80
price down icon 0.03%
大文字化:     |  ボリューム (24 時間):